Kowa Co Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KOWA CO, and when can generic versions of KOWA CO drugs launch?
KOWA CO has one approved drug.
There are two US patents protecting KOWA CO drugs.
There are forty-nine patent family members on KOWA CO drugs in seventeen countries.
Summary for Kowa Co
| International Patents: | 49 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Patent Litigation for Kowa Co: | See patent lawsuits for Kowa Co |
Drugs and US Patents for Kowa Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | AB | RX | Yes | No | 8,557,993*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-003 | Aug 3, 2009 | AB | RX | Yes | Yes | 7,022,713*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-001 | Aug 3, 2009 | AB | RX | Yes | No | 7,022,713*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | AB | RX | Yes | No | 7,022,713*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-003 | Aug 3, 2009 | AB | RX | Yes | Yes | 8,557,993*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-001 | Aug 3, 2009 | AB | RX | Yes | No | 8,557,993*PED | ⤷ Subscribe | Y | ⤷ Subscribe | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Kowa Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-003 | Aug 3, 2009 | 5,854,259 | ⤷ Subscribe |
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | 6,465,477 | ⤷ Subscribe |
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-001 | Aug 3, 2009 | 5,753,675 | ⤷ Subscribe |
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-003 | Aug 3, 2009 | 6,465,477 | ⤷ Subscribe |
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-002 | Aug 3, 2009 | 5,753,675 | ⤷ Subscribe |
| Kowa Co | LIVALO | pitavastatin calcium | TABLET;ORAL | 022363-003 | Aug 3, 2009 | 5,753,675 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for KOWA CO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 1 mg, 2 mg, and 4 mg | ➤ Subscribe | 2013-08-05 |
International Patents for Kowa Co Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 101376449 | ⤷ Subscribe |
| Japan | 5474276 | ⤷ Subscribe |
| Cyprus | 1110133 | ⤷ Subscribe |
| Japan | 2007523049 | ⤷ Subscribe |
| Japan | 2014198743 | ⤷ Subscribe |
| China | 100374422 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
